Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for Vivos Therapeutics (VVOS) over the last 7 years, with Q3 2025 value amounting to $25.6 million.

  • Vivos Therapeutics' Liabilities and Shareholders Equity rose 6709.45% to $25.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.2 million, marking a year-over-year increase of 4564.15%. This contributed to the annual value of $15.3 million for FY2024, which is 4244.18% up from last year.
  • According to the latest figures from Q3 2025, Vivos Therapeutics' Liabilities and Shareholders Equity is $25.6 million, which was up 6709.45% from $26.0 million recorded in Q2 2025.
  • Over the past 5 years, Vivos Therapeutics' Liabilities and Shareholders Equity peaked at $46.2 million during Q2 2021, and registered a low of $10.3 million during Q3 2023.
  • For the 5-year period, Vivos Therapeutics' Liabilities and Shareholders Equity averaged around $21.2 million, with its median value being $17.1 million (2023).
  • As far as peak fluctuations go, Vivos Therapeutics' Liabilities and Shareholders Equity plummeted by 5927.45% in 2022, and later soared by 6709.45% in 2025.
  • Quarter analysis of 5 years shows Vivos Therapeutics' Liabilities and Shareholders Equity stood at $33.7 million in 2021, then crashed by 59.27% to $13.7 million in 2022, then decreased by 21.79% to $10.7 million in 2023, then skyrocketed by 42.44% to $15.3 million in 2024, then skyrocketed by 67.78% to $25.6 million in 2025.
  • Its last three reported values are $25.6 million in Q3 2025, $26.0 million for Q2 2025, and $11.3 million during Q1 2025.